|
FDA加速审批针对罕见杜兴氏肌营养不良症突变的首个靶...
2019.12.12
FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation
The U.S. Food and Drug Administration today granted accelerated approval to Vyondys 53 (golodirsen) injection to treat Duchenne muscular dystr...
|
